Source: Annual Congress 2003 - Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ilonidis, I. Agorastos, G. Anogianakis, P. Koumboudis, A. Anogeianakis (Thessaloniki, Greece). Bronchial hyperreactivity in patients with inflammatory bowel disease. Eur Respir J 2003; 22: Suppl. 45, 3022

Member's Comments

No comment yet.

Related content which might interest you: Airway and lung involvement in inflammatory bowel disease Source: Eur Respir Monogr 2019; 86: 228-261 Year: 2019 Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Bronchial hyperresponsiveness in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Increased incidence of inflammatory bowel disease in Québec residents with airway diseases Source: Eur Respir J 2015; 45: 962-968 Year: 2015 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Inflammatory bowel diseases in COPD patients. Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Diffuse parenchymal lung inflammation response in patients with inflammatory bowel disease Source: Eur Respir J 2005; 26: Suppl. 49, 540s Year: 2005